The repressive activity of hepatitis C virus core protein on the transcription of p21waf1 is regulated by protein kinase A-mediated phosphorylation

被引:30
作者
Jung, EY
Lee, MN
Yang, HY
Yu, DY
Jang, KL [1 ]
机构
[1] Pusan Natl Univ, Coll Nat Sci, Dept Microbiol, Pusan 609735, South Korea
[2] Korea Res Inst Biosci & Biotechnol, Taejon 305333, South Korea
关键词
CDK inhibitor; HCV core protein; p21; PKA; phosphorylation; transcriptional repression;
D O I
10.1016/S0168-1702(01)00335-5
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Hepatitis C virus (HCV) core protein is known to repress the transcription of p21(waf1) directly in a p53-independent manner. In this study, the region of HCV core protein responsible for the transcriptional repression of p21 promoter was determined. N-terminal half of core protein almost completely lost the ability to repress p21 promoter, indicating that the domain required for the majority of p21 repression is located between amino acid positions 84 and 191. The trans-repression activity of HCV core mutant S99L on p21 gene expression was similar to that of wild type core protein whereas mutation of the 116th amino acid Ser into either Ile or Ala completely abolished the repressive ability of HCV core protein. In addition, the trans-repression activity of HCV core mutant S116D was similar to that of wild type core protein, suggesting that an acidic aspartate residue can min-tic the effect of phosphorylation. When treated with a protein kinase A (PKA) inhibitor, H-89, the inhibitory activity of wild-type HCV core protein was dose-dependently decreased and was completely lost at the concentration of 5 muM. On the contrary, the repression activity of HCV core protein was increased by treatment with a PKA activator, dibutyryl-cAMP, indicating that the p21 repressive activity of HCV core protein is regulated by phosphorylation at S-116 by protein PKA (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:109 / 115
页数:7
相关论文
共 19 条
[1]   Hepatitis C virus core from two different genotypes has an oncogenic potential but is not sufficient for transforming primary rat embryo fibroblasts in cooperation with the H-ras oncogene [J].
Chang, J ;
Yang, SH ;
Cho, YG ;
Hwang, SB ;
Hahn, YS ;
Sung, YC .
JOURNAL OF VIROLOGY, 1998, 72 (04) :3060-3065
[2]  
CHO YG, 1993, MOL CELLS, V3, P195
[3]   WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION [J].
ELDEIRY, WS ;
TOKINO, T ;
VELCULESCU, VE ;
LEVY, DB ;
PARSONS, R ;
TRENT, JM ;
LIN, D ;
MERCER, WE ;
KINZLER, KW ;
VOGELSTEIN, B .
CELL, 1993, 75 (04) :817-825
[4]   THE ROUS-SARCOMA VIRUS LONG TERMINAL REPEAT IS A STRONG PROMOTER WHEN INTRODUCED INTO A VARIETY OF EUKARYOTIC CELLS BY DNA-MEDIATED TRANSFECTION [J].
GORMAN, CM ;
MERLINO, GT ;
WILLINGHAM, MC ;
PASTAN, I ;
HOWARD, BH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (22) :6777-6781
[5]  
HOUGHTON M, 1996, VIROLOGY
[6]  
Liu Y, 1996, CANCER RES, V56, P31
[7]   Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-κB activation [J].
Marusawa, H ;
Hijikata, M ;
Chiba, T ;
Shimotohno, K .
JOURNAL OF VIROLOGY, 1999, 73 (06) :4713-4720
[8]  
MICHIELI P, 1994, CANCER RES, V54, P3391
[9]   PRINCIPLES OF CDK REGULATION [J].
MORGAN, DO .
NATURE, 1995, 374 (6518) :131-134
[10]   The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice [J].
Moriya, K ;
Fujie, H ;
Shintani, Y ;
Yotsuyanagi, H ;
Tsutsumi, T ;
Ishibashi, K ;
Matsuura, Y ;
Kimura, S ;
Miyamura, T ;
Koike, K .
NATURE MEDICINE, 1998, 4 (09) :1065-1067